A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus. ... US Food and Drug Administration. February 14, 2025.

Two experts discuss why more research is needed before continuous glucose monitors can be used reliably for insulin ...

While there is no best drug for improving insulin resistance, many drugs can treat the root causes of insulin resistance. These may include obesity, type 2 diabetes, and a sedentary lifestyle.

Georgia Tech engineers have created a pill that could effectively deliver insulin and other injectable drugs, making ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...